bi-shRNA-KRAS

N/A

Report date: 2023/05/17 08:51:35

NME

Base Information

Drug Namebi-shRNA-KRAS

Drug Alias Namebi-shRNA KRAS lipoplex

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionRNA interference

TargetsGTPase KRas

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGradalis Inc

China Registration ClassN/A

Active CompaniesGradalis Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A